Processa Pharmaceuticals Investor Relations Material
Latest events
Q4 2022
Processa Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Processa Pharmaceuticals Inc
Access all reports
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for patients with unmet medical needs. The company is engaged in the research and development of drug candidates aimed at addressing serious conditions across multiple therapeutic areas, including oncology and infectious diseases. Processa Pharmaceuticals' approach involves advancing its drug candidates through clinical trials to provide safer and more effective therapies. Its pipeline targets conditions where current treatment options may be limited or inadequate, aiming to improve patient outcomes and quality of life. The company is headquartered in Hanover, Maryland, and its shares are listed on the NASDAQ.
Latest articles
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Anthony Noto: The Multifaceted CEO of SoFi
Anthony Noto built a successful and diverse career across multiple industries before becoming CEO of the fintech company SoFi.
9 Dec 2024
Master of Tickets: Breaking Down Live Nation Entertainment
Since merging in 2010, Ticketmaster and Live Nation have built an expansive ecosystem that dominates global live entertainment.
6 Dec 2024
Ticker symbol
PCSA
Country
🇺🇸 United States